Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Culprit-Lesion-Only Versus Multivessel Revascularization Using Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: A Korean Acute Myocardial Infarction Registry-Based Analysis

Authors
Jo, Hyun SuPark, Jong SeonSohn, Jang WonYoon, Joon CheolSohn, Chang WooLee, Sang HeeHong, Geu RuShin, Dong GuKim, Young JoJeong, Myung HoChae, Shung ChullHur, Seung HoHong, Taek JongSeong, In WhanChae, Jei KeonRhew, Jay YoungChae, In HoCho, Myeong ChanBae, Jang HoRha, Seung WoonKim, Chong JinChoi, Dong HoonJang, Yang SooYoon, Jung HanChung, Wook SungSeung, Ki BaePark, Seung Jung
Issue Date
Dec-2011
Publisher
KOREAN SOC CARDIOLOGY
Keywords
Myocardial infarction; Coronary artery disease; Angioplasty
Citation
KOREAN CIRCULATION JOURNAL, v.41, no.12, pp.718 - 725
Indexed
SCOPUS
KCI
Journal Title
KOREAN CIRCULATION JOURNAL
Volume
41
Number
12
Start Page
718
End Page
725
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/111069
DOI
10.4070/kcj.2011.41.12.718
ISSN
1738-5520
Abstract
Background and Objectives: In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, complete revascularization (CR) for non-culprit lesions is not routinely recommended. The aim of this study was to compare the clinical outcomes of multivessel compared with infarct-related artery (IRA)-only revascularization in patients undergoing primary percutaneous coronary intervention (PCI) for STEMI. Subjects and Methods: From the Korean Acute Myocardial Infarction Registry (KAMIR) database, 1,094 STEMI patients with multivessel disease who underwent primary PCI with drug-eluting stents were enrolled in this study. The patients were divided into two groups: culprit-vessel-only revascularization (COR, n=827) group; multivessel revascularization, including non-IRA (MVR, n=267) group. The primary endpoint of this study included major adverse cardiac events (MACEs), such as death, myocardial infarction, or target or nontarget lesion revascularization at one year. Results: There was no difference in clinical characteristics between the two groups. During the one-year follow-up, 102 (15.2%) patients in the COR group and 32 (14.2%) in the MVR group experienced at least one MACE (p=0.330). There were no differences between the two groups in terms of rates of death, myocardial infarction, or revascularization (2.1% vs. 2.0%, 0.7% vs. 0.8%, and 11.7% vs. 10.1%, respectively; p=0.822, 0.910, and 0.301, respectively). The MACE rate was higher in the incompletely revascularized patients than in the completely revascularized patients (15% vs. 9.5%, p=0.039), and the difference was attributable to a higher rate of nontarget vessel revascularization (8.6% vs. 1.8%, p=0.002). Conclusion: Although multivessel angioplasty during primary PCI for STEMI did not reduce the MACE rate compared with culprit-vessel-only PCI, CR was associated with a lower rate of repeat revascularization after multivessel PCI.
Files in This Item
There are no files associated with this item.
Appears in
Collections
Graduate School > Department of Biomedical Sciences > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Rha, Seung Woon photo

Rha, Seung Woon
Department of Biomedical Sciences
Read more

Altmetrics

Total Views & Downloads

BROWSE